标题
Therapeutic Efficacy of Bevacizumab for Age-Related Macular Degeneration
作者
关键词
-
出版物
DRUGS & AGING
Volume 28, Issue 11, Pages 853-865
出版商
Springer Nature
发表日期
2011-10-05
DOI
10.2165/11594720-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Addressing Missing Data in Clinical Trials
- (2013) Thomas R. Fleming ANNALS OF INTERNAL MEDICINE
- Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
- (2011) Ross J. Brechner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Comparing protein VEGF inhibitors: In vitro biological studies
- (2011) Lanlan Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells
- (2011) H. L. Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab
- (2011) Paul Mitchell CURRENT MEDICAL RESEARCH AND OPINION
- A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications
- (2011) S P Kelly et al. EYE
- One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration
- (2011) S Arora et al. EYE
- Retreatment criteria in anti-VEGF therapy of exudative AMD: critical analysis of present regimes and new morphological definition of “lesion activity”
- (2011) Daniel Pauleikhoff et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Spectral-Domain versus Time Domain Optical Coherence Tomography before and after Ranibizumab for Age-Related Macular Degeneration
- (2011) Giuseppe Querques et al. OPHTHALMIC RESEARCH
- Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
- (2011) Paul Mitchell et al. PHARMACOECONOMICS
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab
- (2010) Alexandros N. Stangos et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Beneficent Persuasion: Techniques and Ethical Guidelines to Improve Patients' Decisions
- (2010) J. S. Swindell et al. ANNALS OF FAMILY MEDICINE
- Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
- (2010) Lesley H. Curtis ARCHIVES OF OPHTHALMOLOGY
- Rapid Expansion of Intravitreal Drug Injection Procedures, 2000 to 2008
- (2010) Robert J. Campbell ARCHIVES OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
- (2010) C. Schmucker et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation
- (2010) William Hodge et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system
- (2010) Aljoscha S. Neubauer et al. CLINICAL THERAPEUTICS
- The blind leading the blind: Use and misuse of blinding in randomized controlled trials
- (2010) Larry E. Miller et al. Contemporary Clinical Trials
- Intracellular bevacizumab reduces phagocytotic uptake in RPE cells
- (2010) Alexa Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity
- (2010) Philipp Sebastian Muether et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Identifying and Eliminating the Roadblocks to Comparative-Effectiveness Research
- (2010) Daniel F. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye
- (2010) Neil M. Bressler et al. OPHTHALMOLOGY
- Agreement of Time-Domain and Spectral-Domain Optical Coherence Tomography with Fluorescein Leakage from Choroidal Neovascularization
- (2010) Rahul N. Khurana et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- A COST-EFFECTIVENESS ANALYSIS OF THREE TREATMENTS FOR AGE-RELATED MACULAR DEGENERATION
- (2010) EMILY W. GOWER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies
- (2009) Karl Csaky et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A Perspective on Commercial Relationships Between Ophthalmology and Industry
- (2009) Lee M. Jampol ARCHIVES OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration
- (2009) Focke Ziemssen et al. DRUGS & AGING
- Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells
- (2009) Alexa Karina Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Pharmaceutical company–sponsored drug trials: what are we to believe?
- (2009) Paul Shekelle JOURNAL OF CLINICAL EPIDEMIOLOGY
- Which Providers Should Communicate Which Critical Information About a New Medication? Patient, Pharmacist, and Physician Perspectives
- (2009) Derjung M. Tarn et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Continuing Medical Education, Physicians, and Pavlov
- (2008) Paul R. Lichter ARCHIVES OF OPHTHALMOLOGY
- Predicted biological activity of intravitreal VEGF Trap
- (2008) M W Stewart et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Patients’ Beliefs and Preferences Regarding Doctors’ Medication Recommendations
- (2008) Sarah L. Goff et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization
- (2008) Qi Zhu et al. OPHTHALMOLOGY
- What are the external influences on information exchange and shared decision-making in healthcare consultations: A meta-synthesis of the literature
- (2008) Michelle Edwards et al. PATIENT EDUCATION AND COUNSELING
- The Reversal of Fortunes: Trends in County Mortality and Cross-County Mortality Disparities in the United States
- (2008) Majid Ezzati et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More